Shore Capital Partners ("Shore" or "Shore Capital"), a Chicago-based private equity firm with offices in Nashville, today announced the merger of Reliant Healthcare ("Reliant") and Care Fusion Rx ...

Vyvo Therapeutics has announced the launch of its IV therapy service, now available at its medical spa located at 2817 W Loop ...

Preparing for infusion therapy is nothing like it was in the past. Tech meets wellness with ivee, which means you can now arrange to have your infusion therapy treatments done directly from the ...

GREENVILLE, S.C. (WSPA)– Infusion has long been a standard delivery method of chemotherapy for cancer patients. But, did you know that it’s also used to treat other conditions and diseases? We spoke ...

Infusion therapy provides life-saving treatment to patients with a host of conditions, but it requires regular visits, being poked with a needle, and of course, time. However, thanks to services like ...

The Preserving Patient Access to Home Infusion Act protects access to Medicare’s home infusion benefit by making clear that pharmacy services for home infusion therapy can be reimbursed. The ...

In 2020, Darzalex Faspro (the Sub-Q version) changed the game. The infusion time went from three hours (or an hour and a half ...

ARLINGTON, Texas--(BUSINESS WIRE)--AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited distribution partner for ...

Rochester, N.Y. — The FDA has granted an Emergency Use Authorization for Evusheld, a therapy to inject COVID antibodies in individuals who are immune suppressed and don’t mount an adequate response to ...

Members of the National Home Infusion Association (NHIA) on Nov. 6 participated in more than 130 meetings with members of ...

Tepezza (teprotumumab-trbw) is a prescription drug that’s used to treat thyroid eye disease (TED). Tepezza comes as a powder that’s mixed with sterile water to make a liquid solution. It’s given by ...

A quiet hope has started to grow among people living with stubborn cholesterol problems as researchers report early success ...